Androgenetic alopecia may be associated with weaker COVID-19 T-cell immune response: An insight into a potential COVID-19 vaccine booster.

Goren A, Cadegiani FA, Wambier CG, Vano-Galvan S, Tosti A, Shapiro J, Mesinkovska NA, Ramos PM, Sinclair R, Lupi O, Hercogova J, McCoy J.
Med Hypotheses. 2020 Nov 28:110439. doi: 10.1016/j.mehy.2020.110439. Online ahead of print.

5-alpha-reductase inhibitors are associated with reduced frequency of COVID-19 symptoms in males with androgenetic alopecia

McCoy J, Cadegiani FA, Wambier CG, Herrera S, Vaño-Galván S, Mesinkovska NA, Ramos PM, Shapiro J, Sinclair R, Tosti A, Goren A.
J Eur Acad Dermatol Venereol. 2020 Nov 2. doi: 10.1111/jdv.17021. Online ahead of print.

Clinical symptoms of hyperandrogenic women diagnosed with COVID-19.

Cadegiani FA, Lim RK, Goren A, McCoy J, Situm M, Kovacevic M, Vañó Galván S, Sinclair R, Tosti A, Wambier CG.
J Eur Acad Dermatol Venereol. 2020 Oct 21. doi: 10.1111/jdv.17004. Online ahead of print.

Anti-androgens may protect against severe COVID-19 outcomes: results from a prospective cohort study of 77 hospitalized men.

Goren A, Wambier CG, Herrera S, McCoy J, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Ramos PM, Cadegiani FA, Kovacevic M, Tosti A, Shapiro J, Sinclair R.
J Eur Acad Dermatol Venereol. 2020 Sep 25. doi: 10.1111/jdv.16953. Online ahead of print.

The COVID-19 pandemic has disproportionally affected men.(1) Men infected with SARS-CoV-2 are more than twice as likely to be admitted to the intensive care unit (ICU).(2) This disparity in ICU admissions suggests the important role of androgens in COVID-19 severity …

Androgen Receptor Genetic Variant Predicts COVID-19 Disease Severity: A Prospective Longitudinal Study of Hospitalized COVID-19 Male Patients.

McCoy J, Wambier CG, Herrera S, Vaño-Galván S, Gioia F, Comeche B, Ron R, Serrano-Villar S, Iwasiow RM, Tayeb MA, Cadegiani FA, Mesinkovska NA, Shapiro J, Sinclair R, Goren A.
J Eur Acad Dermatol Venereol. 2020 Sep 25. doi: 10.1111/jdv.16956. Online ahead of print.

Male balding as a major risk factor for severe COVID-19: a possible role for targeting androgens and transmembrane protease serine 2 to protect vulnerable individuals

Carlos Gustavo Wambier, John McCoy, Andy Goren
J Am Acad Dermatol. 2020 Sep 11:S0190-9622(20)32600-1. doi: 10.1016/j.jaad.2020.09.015. Online ahead of print.

Androgen sensitivity in COVID-19 and antiandrogens: Prospective data are still needed.

Ianhez M, Ramos PM, Goren A, Miot HA.
Dermatol Ther. 2020 Aug 9:e14166. doi: 10.1111/dth.14166. Online ahead of print.

Are night shift workers at an increased risk for COVID-19?

Lim RK, Wambier CG, Goren A.
Med Hypotheses. 2020 Jul 29;144:110147. doi: 10.1016/j.mehy.2020.110147. Online ahead of print.

Recent data has revealed an association between coronavirus disease-19 (COVID-19) incidence and seasonally regulated androgen sensitivity. This potential relationship between SARS-CoV-2 infection and clock genes, coupled with previously reported effects of night shift work …

Spironolactone: An Anti-androgenic and Anti-hypertensive Drug That May Provide Protection Against the Novel Coronavirus (SARS-CoV-2) Induced Acute Respiratory Distress Syndrome (ARDS) in COVID-19.

Cadegiani FA, Wambier CG, Goren A.
Front Med (Lausanne). 2020 Jul 28;7:453. doi: 10.3389/fmed.2020.00453. eCollection 2020.

Spironolactone may provide protection from SARS-CoV-2: Targeting androgens, angiotensin converting enzyme 2 (ACE2), and renin-angiotensin-aldosterone system (RAAS).

Cadegiani FA, Goren A, Wambier CG.
Med Hypotheses. 2020 Jul 16;143:110112. doi: 10.1016/j.mehy.2020.110112. Online ahead of print.

In coronavirus disease-19 (COVID-19), four major factors have been correlated with worse prognosis: aging, hypertension, obesity, and exposure to androgen hormones. ...Hence, spironolactone may provide protection from SARS-CoV-2, and has sufficient plausibility to be clini …

Clock genes may drive seasonal variation in SARS-CoV-2 infectivity: are we due for a second wave of COVID-19 in the fall?

Goren A, Wambier CG, McCoy J, Shapiro J, Vaño-Galván S, Herrera S, Glode LM.
J Biol Regul Homeost Agents. 2020 Jul 16;34(4). doi: 10.23812/20-359-L-35. Online ahead of print.

Androgenetic alopecia in COVID-19: compared to age-matched epidemiologic studies and hospital outcomes with or without the Gabrin sign.

Wambier CG, Vaño-Galván S, McCoy J, Pai S, Dhurat R, Goren A.
J Am Acad Dermatol. 2020 Jul 28:S0190-9622(20)32300-8. doi: 10.1016/j.jaad.2020.07.099. Online ahead of print.

Safety Measures in Dermatology Help Minimize Spread of COVID-19.

Goren A, Rathod D, Kroumpouzos G, Jafferany M, Goldust M.
Dermatol Ther. 2020 Jun 7. doi: 10.1111/dth.13773. Online ahead of print.

Microneedling improves minoxidil response in androgenetic alopecia patients by upregulating follicular sulfotransferase enzymes.

Sharma A, Surve R, Dhurat R, Sinclair R, Tan T, Zou Y, Müller Ramos P, Wambier C, Verner I, Kovacevic M, Goren A.
J Biol Regul Homeost Agents. 2020 Mar-Apr;34(2):659-661. doi: 10.23812/19-385-L-51.

Androgenetic Alopecia Present in the Majority of Hospitalized COVID-19 Patients - the "Gabrin sign".

Wambier CG, Vaño-Galván S, McCoy J, Gomez-Zubiaur A, Herrera S, Hermosa-Gelbard Á, Moreno-Arrones OM, Jiménez-Gómez N, González-Cantero A, Pascual PF, Segurado-Miravalles G, Shapiro J, Pérez-García B, Goren A.
J Am Acad Dermatol. 2020 May 21:S0190-9622(20)30948-8. doi: 10.1016/j.jaad.2020.05.079. Online ahead of print.

Novel Topical Booster Enhances Follicular Sulfotransferase Activity in Patients with Androgenetic Alopecia: A New Strategy to Improve Minoxidil Response.

Ramos PM, McCoy J, Wambier C, Shapiro J, Vañó-Galvan S, Sinclair R, Goren A.
J Eur Acad Dermatol Venereol. 2020 May 20. doi: 10.1111/jdv.16645. Online ahead of print.

Androgen sensitivity gateway to COVID-19 disease severity.

Wambier CG, Goren A, Vaño-Galván S, Ramos PM, Ossimetha A, Nau G, Herrera S, McCoy J.
Drug Dev Res. 2020 May 15:10.1002/ddr.21688. doi: 10.1002/ddr.21688. Online ahead of print.

Topical Alpha-1 Adrenergic Receptor Agonist Applied to the Nipple/Areola Complex Improves Female Orgasmic Function.

Goren A, McCoy J, Krychman M, Brandt L, Lah A, Lonky N.
J Womens Health (Larchmt). 2020 May 12. doi: 10.1089/jwh.2019.8188. Online ahead of print.

Allergic contact dermatitis in patients with frontal fibrosing alopecia: An international multi-center study.

Rudnicka L, Rokni GR, Lotti T, Wollina U, Fölster-Holst R, Katsambas A, Goren A, Di Lernia VG, Rathod D, Mirabi A, Ghaffari A, Rajan A, Goldust M.
Dermatol Ther. 2020 May 12:e13560. doi: 10.1111/dth.13560. Online ahead of print.

Novel yeast extract is superior to colloidal oatmeal in providing rapid itch relief.

Dhurat R, Sharma A, Surve R, McCoy J, Kovacevic M, Goren A, Tan Y, Zou Y, Goldust M, Situm M, Stanimirovic A.
J Cosmet Dermatol. 2020 May 2. doi: 10.1111/jocd.13436. Online ahead of print.

Racial Variations in COVID-19 Deaths May Be Due to Androgen Receptor Genetic Variants Associated with Prostate Cancer and Androgenetic Alopecia. Are Anti-Androgens a Potential Treatment for COVID-19?

McCoy J, Wambier CG, Vano-Galvan S, Shapiro J, Sinclair R, Müller Ramos P, Washenik K, Andrade M, Herrera S, Goren A.
J Cosmet Dermatol. 2020 Apr 25:10.1111/jocd.13455. doi: 10.1111/jocd.13455. Online ahead of print.

A preliminary observation: Male pattern hair loss among hospitalized COVID-19 patients in Spain - A potential clue to the role of androgens in COVID-19 severity.

Goren A, Vaño-Galván S, Wambier CG, McCoy J, Gomez-Zubiaur A, Moreno-Arrones OM, Shapiro J, Sinclair RD, Gold MH, Kovacevic M, Mesinkovska NA, Goldust M, Washenik K.
J Cosmet Dermatol. 2020 Apr 16. doi: 10.1111/jocd.13443. Online ahead of print.

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection is likely to be androgen mediated.

Wambier CG, Goren A.
J Am Acad Dermatol. 2020 Apr 10:S0190-9622(20)30608-3. doi: 10.1016/j.jaad.2020.04.032. Online ahead of print.

What does androgenetic alopecia have to do with COVID-19? An insight into a potential new therapy.

Goren A, McCoy J, Wambier CG, Vano-Galvan S, Shapiro J, Dhurat R, Washenik K, Lotti T.
Dermatol Ther. 2020 Apr 1:e13365. doi: 10.1111/dth.13365. Online ahead of print.

STAT3-mutated hyperimmunoglobulin E syndrome with perianal skin tags and erosions: A case report.

Fölster-Holst R, Kazeminejad A, Rokni GR, Lotti T, Goren A, Goldust M.
Dermatol Ther. 2020 Mar 26:e13333. doi: 10.1111/dth.13333. Online ahead of print.

Low-level laser therapy and narrative review of other treatment modalities in androgenetic alopecia.

Galadari H, Shivakumar S, Lotti T, Wollina U, Goren A, Rokni GR, Grabbe S, Goldust M.
Lasers Med Sci. 2020 Mar 11. doi: 10.1007/s10103-020-02994-4. Online ahead of print.

Erosive pustular dermatosis of the scalp: a multicentre study.

Starace M, Iorizzo M, Trüeb RM, Piccolo V, Argenziano G, Camacho FM, Gallyamova Y, Rudnicka L, Umbert I, Lyakhovitsky A, Vañó-Galván S, Goren A, Alessandrini A, Bruni F, Piraccini BM.
J Eur Acad Dermatol Venereol. 2020 Jan 18. doi: 10.1111/jdv.16211. Online ahead of print.

Yeast extract demonstrates rapid itch relief in chronic pruritus.

Zhang Y, Tan Y, Zou Y, Bulat V, Lugovic Mihic L, Kovacevic M, Lotti T, Verner I, Stanimirovic A, Situm M, Goldust M, Liu W, Vojvodic A, Goren A.
J Cosmet Dermatol. 2020 Jan 10. doi: 10.1111/jocd.13265. Online ahead of print.

Non-ablative radio frequency for the treatment of androgenetic alopecia.

Tan Y, Wei L, Zhang Y, Goren A, McCoy J, Stanimirovic A, Lotti T, Kovacevic M.
Acta Dermatovenerol Alp Pannonica Adriat. 2019 Dec;28(4):169-171.

Can we halt male androgenetic alopecia progression without antiandrogenic drugs?

Ramos PM, Santos LDN, Mesinkovska NA, Goren A, Miot HA.
Dermatol Ther. 2020 Jan;33(1):e13197. doi: 10.1111/dth.13197. Epub 2020 Jan 2.

Novel topical formulation applied to the nipple-areola complex improves female orgasm.

Krychman M, Goren A, Brandt L, McCoy J.
J Cosmet Dermatol. 2020 Feb;19(2):404-406. doi: 10.1111/jocd.13262. Epub 2019 Dec 17.

Sulfotransferase activity in plucked hair follicles predicts response to topical minoxidil treatment in Brazilian female pattern hair loss patients.

Ramos PM, Sinclair R, Miot HA, Goren A.
Dermatol Ther. 2020 Jan;33(1):e13195. doi: 10.1111/dth.13195. Epub 2019 Dec 27.

Efficacy of topical latanoprost in the treatment of eyelid vitiligo: A randomized, double-blind clinical trial study.

Nowroozpoor Dailami K, Hosseini A, Rahmatpour Rokni G, Saeedi M, Morteza-Semnani K, Sadeghi Z, Ghasemzadeh Diva SM, Goldust M, Lotti T, Vojvodic A, Goren A, Sonthalia S, Rathod D.
Dermatol Ther. 2020 Jan;33(1):e13175. doi: 10.1111/dth.13175. Epub 2019 Dec 26.

Vemurafenib and cobimetinib-induced toxic epidermal necrolysis in a patient with metastatic melanoma.

Poduje S, Brozić JM, Prkačin I, Delaš Aždajić M, Goren A.
Dermatol Ther. 2020 Jan;33(1):e13174. doi: 10.1111/dth.13174. Epub 2019 Dec 11.

The impact of short tandem repeat variation on gene expression.

Fotsing SF, Margoliash J, Wang C, Saini S, Yanicky R, Shleizer-Burko S, Goren A, Gymrek M.
Nat Genet. 2019 Nov;51(11):1652-1659. doi: 10.1038/s41588-019-0521-9. Epub 2019 Nov 1.

Oral minoxidil bio-activation by hair follicle outer root sheath cell sulfotransferase enzymes predicts clinical efficacy in female pattern hair loss.

Ramos PM, Goren A, Sinclair R, Miot HA.
J Eur Acad Dermatol Venereol. 2020 Jan;34(1):e40-e41. doi: 10.1111/jdv.15891. Epub 2019 Sep 11.

Radio Frequency in the Treatment of Androgenetic Alopecia

Goren et al.
Journal of Cosmetic Dermatology (Submitted 2019)

Novel Shampoo Reduces Hair Shedding by Contracting the Arrector Pili Muscle via the Trace Amine Associate Receptor

Goren et al.
Journal of Cosmetic Dermatology (Accepted 2019)

Evaluation of the diabetogenic effect of methotrexate in psoriatic arthritis patients with metabolic syndrome, a pilot study

Dehpouri et al.
Dermatology Reports 2019; volume 11:7965

MISSION IMPOSSIBLE: DERMAL DELIVERY OF GROWTH FACTORS VIA MICRONEEDLING

Dhurat R, Sharma A, Goren A, Daruwalla S, Situm M, Kovacevic M.
J.Dermatol Ther. (Accepted 2019)

Tretinoin Enhances Minoxidil Response in Androgenetic Alopecia Patients by Up-Regulating Follicular Sulfotransferase Enzymes

Aseem Sharma, Andy Goren, Rachita Dhurat, Sandip Agrawal, Rodney Sinclair, Ralph Trueb, Sergio Vano-Galvan, Guangping Chen, Yamili Tan, Maja Kovacevic, Mirna Situm, John McCoy.
J.Dermatol Ther. (Accepted 2019)

Identification of the Sulfotransferase Iso-Enzyme Primarily Responsible for the Bio-Activation of Topical Minoxidil

J McCoy, A Goren, T Naccarato1, M Kovacevic, M Situm, VL Skudar, T Lotti.
J Biol Regul Homeost Agents (Pending Publication).

History of Vitiligo

Kovacevic Maja, Franceschi Nika, Situm Mirna, Goren Andy, Stanimirovic Andrija, Valle Yan, Lotti Torello.
Springer (Pending Publication).

Platelet Rich Plasma in Androgenetic Alopecia: A Systematic Review

Lotti T., Goren A., Verner I. d’Alessio P., Franca K.
J.Dermatol Ther. (Pending Publication).

Integrative Dermatology: The Microbiome in Hair Disorders

Goren A, Situm M, Kovacevic M, McCoy J, Lotti T.
Wiley (Pending Publication).

Frontal Pattern Hair Loss Among Chinese Women is Frequently Associated with Ponytail Hairstyle

Goren A. Wei L., Yimei T., Kovacevic M., McCoy J., Lotti T.
Dermatol Ther. 2018 Nov 20:e12784. doi: 10.1111/dth.12784.

Low Dose Daily Aspirin Reduces Topical Minoxidil Efficacy in Androgenetic Alopecia Patients

Goren A., Sharma A., Dhurat R., Shapiro J., Sinclair R., Situm M., Kovacevic M., Skudar L V., Goldust M.,Lotti T., McCoy J.
Dermatol Ther. 2018 Nov;31(6):e12741. doi: 10.1111/dth.12741. Epub 2018 Oct 8.

Anterior, Frontal Congenital Triangular Alopecia, Redundancy in Therapy without Improvement; A Case Report

Goldust M, Rokni G, Sadr S, Mirabi A, Goren A, Lotti T.
J.Dermatol Ther. (Accepted July 24, 2018)

Minoxidil in the Treatment of Androgenetic Alopecia

Goren A., Naccarato T.
J.Dermatol Ther. (Accepted July 16, 2018)

Characterization of follicular minoxidil sulfotransferase activity in a cohort of pattern hair loss patients in Indian subcontinent

Jill Chitalia, MD, Rachita Dhurat, MD, Andy Goren, MD, John McCoy, PhD, Maja Kovacevic, MD, Mirna Situm, MD, Ty Naccarato, Torello Lotti, MD
J.Dermatol Ther. (Accepted July 10, 2018)

The Effect of Topical Minoxidil Treatment on Follicular Sulfotransferase Enzymatic Activity.

Goren A, McCoy J, Kovacevic M, Situm M, Chitalia J, Dhurat R, Naccarato T, Lotti T.
J Biol Regul Homeost Agents. (Accepted June 11, 2018)

Controversies in the Treatment of Androgenetic Alopecia: The History of Finasteride.

Goren A, McCoy J, Situm M, Dhurat R, Krychman M, Kovacevic M, Sharma A, Bolanca Z.
J.Dermatol Ther. (Accepted June 12, 2018)

Styling without shedding: Novel topical formula reduces hair shedding by contracting the arrector pili muscle.

McCoy J, Goren A, Kovacevic M, Situm M, Stanimirovic A, Shapiro J, Sinclair R.
Dermatol Ther. 2018 Jan;31(1). doi: 10.1111/dth.12575. Epub 2017 Nov 28. PubMed PMID: 29193553.

Micro - Focused Phototherapy Associated To Janus Kinase Inhibitor: A Promising Valid Therapeutic Option for Patients with Localized Vitiligo.

Gianfaldoni S, Tchernev G, Wollina U, Roccia MG, Fioranelli M, Lotti J, Rovesti M, Satolli F, Valle Y, Goren A, Tirant M, Situm M, Kovacevic M, França K, Lotti T.
Open Access Maced J Med Sci. 2018 Jan 21;6(1):46-48. doi: 10.3889/oamjms.2018.042. eCollection 2018 Jan 25. PubMed PMID: 29483979; PubMed Central PMCID: PMC5816312.

Social selection favours offspring prone to the development of androgenetic alopecia.

Goren A, Shapiro J, Naccarato T, Situm M, Kovacevic M, Lonky N, Lotti T, McCoy J.
2017 Oct-Dec;31(4):1013-1016. PubMed PMID: 29254307.

Mechanism of action of minoxidil in the treatment of androgenetic alopecia is likely mediated by mitochondrial adenosine triphosphate synthase-induced stem cell differentiation.

Goren A, Naccarato T, Situm M, Kovacevic M, Lotti T, McCoy J.
2017 Oct-Dec;31(4):1049-1053. PubMed PMID: 29254313.

Potential risk of developing herpes simplex encephalitis in patients treated with sildenafil following primary exposure to genital herpes.

Goren A, McCoy J, Kovacevic M, Situm M, Lonky N.
J Biol Regul Homeost Agents. 2017 Jul-Sep;31(3):679-682. PubMed PMID: 28956417.

Novel technique for repigmentation of senescence grey hair.

Goren A, Bolanča Ž, Lotti T, Šitum M.
Dermatol Ther. 2017 Mar;30(2). doi: 10.1111/dth.12436. Epub 2016 Dec 5. PubMed PMID: 27917579.

Melanin of the nipple areola complex.

Goren A, Kovacevic M, Lotti T.
J Biol Regul Homeost Agents. 2017 Jan-Mar;31(1):237-238. PubMed PMID: 28337898.

Minoxidil dose response study in female pattern hair loss patients determined to be non-responders to 5% topical minoxidil.

McCoy J, Goren A, Kovacevic M, Shapiro J.
2016 Oct-Dec;30(4):1153-1155. PubMed PMID: 28078868.

Prevalence of Hair Shedding Among Women.

Kovacevic M, Goren A, Shapiro J, Sinclair R, Lonky NM, Situm M, Bulat V, Bolanca Z, McCoy J.
Dermatol Ther. 2016 Oct 6. doi: 10.1111/dth.12415.

Platelet-rich Plasma as a Novel Treatment for Lichen Planopillaris.

Bolanča Ž, Goren A, Getaldić-Švarc B, Vučić M, Šitum M.
Dermatol Ther. 2016 Jul;29(4):233-5.

Mixed Vitiligo of Blaschko Lines: a Newly Discovered Presentation of Vitiligo Responsive to Combination Treatment.

Kovacevic M, Stanimirovic A, Vucic M, Goren A, Situm M, Lukinovic Skudar V, Lotti T.
Dermatol Ther. 2016 Jul;29(4):240-3.

α1 -AR Agonist Induced Piloerection Protects Against the Development of Traction Alopecia.

Goren A, Shapiro J, Sinclair R, Kovacevic M, McCoy J.
Dermatol Ther. 2016 May;29(3):160-3.

Management of Chronic Pruritus with a UV Filtering Topical Cream.

Zanardelli M, Kovacevic M, McCoy J, Wang X, Goren A, Lotti T.
Dermatol Ther. 2016 Mar-Apr;29(2):101-3.

Platelet-rich plasma as a novel treatment for lichen planopillaris.

Bolanča Ž, Goren A, Getaldić-Švarc B, Vučić M, Šitum M.
Dermatol Ther. 2016 Jul;29(4):233-5. doi: 10.1111/dth.12343. Epub 2016 Mar 14. PubMed PMID: 26988129.

Doppler Laser Imaging Predicts Response to Topical Minoxidil in the Treatment of Female Pattern Hair Loss.

McCoy J, Kovacevic M, Situm M, Stanimirovic A, Bolanca Z, Goren A.
J Biol Regul Homeost Agents. 2016 Jan-Mar;30(1):131-4.

ProDrugs in Dermatology

Goren A, McCoy J, Lotti T.
European Handbook of Dermatological Treatments. 2015. ISBN 978-3-662-45139-7.

Melanocytes Precursor Cells as a Novel Treatment for Vitiligo.

Zanardelli M, Goren A, Lotti T.
G Ital Dermatol Venereol. 2015 Dec 23.

Clinical Utility and Validity of Minoxidil Response Testing in Androgenetic Alopecia.

Goren A, Shapiro J, Roberts J, McCoy J, Desai N, Zarrab Z, Pietrzak A, Lotti T.
Dermatol Ther. 2015 Jan-Feb;28(1):13-6.

Topical Cream Delivers NB-UVB from Sunlight for the Treatment of Vitiligo.

Wang X, McCoy J, Lotti T, Goren A.
Expert Opin Pharmacother. 2014 Dec;15(18):2623-7.

Novel Topical Cream Delivers Safe and Effective Alternative to Traditional Psoriasis Phototherapy.

Goren A, Salafia A, McCoy J, Keene S, Lotti T, Petrusevska A.
Dermatol Ther. 2014 Sep-Oct;27(5):260-3.

Sulfotransferase Activity in Plucked Hair Follicles Predicts Response to Topical Minoxidil in the Treatment of Female Androgenetic Alopecia.

Roberts J, Desai N, McCoy J, Goren A.
Dermatol Ther. 2014 Jul-Aug;27(4):252-4.

Novel Topical Cream Delivers Safe and Effective Sunlight Therapy for Vitiligo by Selectively Filtering Damaging Ultraviolet Radiation.

Goren A, Salafia A, McCoy J, Keene S, Lotti T.
Dermatol Ther. 2014 Jul-Aug;27(4):195-7.

Acute Telogen Effluvium Onset Event is Associated with the Presence of Female Androgenetic Alopecia: Potential Therapeutic Implications.

Perez-Mora N, Goren A, Velasco C, Bermudez F.
Dermatol Ther. 2014 May-Jun;27(3):159-62.

Novel Enzymatic Assay Predicts Minoxidil Response in the Treatment of Androgenetic Alopecia.

Goren A, Castano JA, McCoy J, Bermudez F, Lotti T.
Dermatol Ther. 2014 May-Jun;27(3):171-3.

In Vitro Evaluation of a Novel Topical Cream for Vitiligo and Psoriasis that Selectively Delivers NB-UVB Therapy When Exposed to Sunlight.

McCoy J, Goren A, Lotti T.
Dermatol Ther. 2014 Mar-Apr;27(2):117-20.

Therapeutic Hotline. Genetic Variations in the Androgen Receptor Gene and Finasteride Response in Women with Androgenetic Alopecia Mediated by Epigenetics.

Keene S, Goren A.
Dermatol Ther. 2011 Mar-Apr;24(2):296-300.